Neurocrine Biosciences shares owned by AIA Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by AIA Group
from 13F filings
Historical chart of AIA Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by AIA Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by AIA Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $224k | 1.8k | 125.69 |
| 2025-03-31 | $214k | 1.9k | 110.60 |
| 2024-12-31 | $232k | 1.7k | 136.50 |
| 2023-03-31 | $213k | 2.1k | 101.22 |
| 2022-12-31 | $290k | 2.4k | 119.44 |
| 2022-06-30 | $160k | 1.6k | 97.56 |